Evidence map›Paper›PMID 35864530›Full record

ArticleCost effectiveness and resource allocation : C/E2022

Tracking malaria health disbursements by source in Zambia, 2009-2018: an economic modelling study.

Michael Mtalimanja, Kassim Said Abasse, Muhammad Abbas, James Lamon Mtalimanja, Xu Zhengyuan, DuWenwen, Andre Cote, Wei Xu

Abstract read
In one paragraph

Article in Cost effectiveness and resource allocation : C/E, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael MtalimanjaSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, Jiangsu, China.
Kassim Said AbasseCentre de Recherche en Gestion Des Services de Sante, Faculté Des Sciences de L'administration (FSA), Université Laval (UL), Centre Hospitalière Universitaire (CHU) de Québec UL-IUCPQ-UL, Québec, QC, Canada.
Muhammad AbbasRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
James Lamon MtalimanjaDepartment of Monitoring and Evaluation, Ministry of Health, P.O Box, 30205, Lusaka, Zambia.
Xu ZhengyuanSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, Jiangsu, China.
DuWenwenSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, Jiangsu, China.
Andre CoteCentre de Recherche en Gestion Des Services de Sante, Faculté Des Sciences de L'administration (FSA), Université Laval (UL), Centre Hospitalière Universitaire (CHU) de Québec UL-IUCPQ-UL, Québec, QC, Canada.
Wei XuSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, Jiangsu, China. xuwei@cpu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundZambia has made profound strides in reducing both the incidence and prevalence of malaria followed by reducing malaria related deaths between 2009 and 2018. The number of partners providing malaria funding has significantly increased in the same period. The increasing number of partners and the subsequent reduction of the number of reported malaria cases in the Ministry of Health main data repository Health Management Information System (HMIS) stimulated this research. The study aimed at (1) identifying major sources of malaria funding in Zambia; (2) describe malaria funding per targeted interventions and (3) relating malaria funding with malaria disease burden.

methodsData was collected using extensive literature review of institutional strategic document between the year 2009 to 2018, assuming one-year time lag between investment and the health outcome across all interventions. The National's Health Management Information System (HMIS) provided information on annual malaria admission cases and outpatient clinic record. The statistical package for social sciences (SPSS) alongside Microsoft excel was used to analyze data in the year 2019.

resultsThe investigation observed that about 30% of the funding came from PMI/USAID, 26% from the global funds, the government of Zambia contributed 17% and other partners sharing the remaining 27%. Multivariate regression analysis suggests a positive correlation between reducing reported malaria disease burden in HMIS 2009-2018 and concurrent increasing program/intervention funding towards ITNs, IRS, MDA, and Case Management with r

conclusionOur findings highlight annual funding towards specific malaria intervention reduced the number of malaria admission cases.

Indexed as

Disease BurdenMalaria fundingMalaria interventionsZambia

Identifiers

PMID35864530
PMCPMC9306103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.